PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Bio-Rad Laboratories, Inc.
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bio-Rad Launches CFX Manager Software Version 1.5 - Enables Researchers to easily set up real-time PCR experiments and analyze data using Bio-Rad's CFX96, CFX384, and MiniOpticon real-time PCR systems -
Bio-Rad Launches CFX Manager Software Version 1.5


NewswireToday - /newswire/ - Hercules, CA, United States, 2009/07/06 - Enables Researchers to easily set up real-time PCR experiments and analyze data using Bio-Rad's CFX96, CFX384, and MiniOpticon real-time PCR systems - AMEX: BIO; BIOb

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of its CFX Manager™ software version 1.5, a key component of Bio-Rad's 1000-series thermal cycling platform. CFX Manager software version 1.5 controls Bio-Rad's CFX96™, CFX384™, and MiniOpticon™ real-time PCR detection systems. Whether performing a first real-time PCR experiment or analyzing a comprehensive gene expression study, CFX Manager software enables researchers to easily set up experiments and analyze data.

The combination of the easy-to-use, powerful data analysis capabilities of CFX Manager software version 1.5 and the compact, portable MiniOpticon provides the ideal solution for researchers requiring medium to low throughput real-time PCR. Built on Bio Rad's MJ Mini™ thermal cycler, the MiniOpticon's two-color multiplexing capability can detect a range of fluorophores for real-time PCR applications and gel-free PCR analysis.

Pairing the CFX96 or CFX384 systems with CFX Manager software version 1.5, researchers can conduct high-throughput real-time PCR even faster. Compatible with Bio-Rad's C1000™ thermal cycler platform, the CFX96 and CFX384 systems deliver sensitive, reliable detection for real-time PCR applications, including absolute quantitation, genetic variation analysis, and gene expression.

CFX Manager software version 1.5 key features include the following:

• Startup wizard and intuitive navigation — users are able to quickly get up and running;
• Flexible record keeping — users can enter or edit PCR plate information before, during, or after a run;
• Customizable settings — users can customize experiment setup and data analysis;
• Email notification upon run completion — users can receive an attached data file or report so they can analyze results when and where they want;
• Well Groups — users can analyze multiple experiments from a single plate, each with its own analysis settings;
• Advanced analysis tools — users can perform normalized gene expression using multiple reference genes, gene stability values, and individual reaction efficiencies.

CFX Manager software version 1.5 is also available in Chinese and Russian editions. These localized language editions are the first in the real-time PCR market to display a user interface in either Chinese or Russian. The Chinese and Russian versions of the software have all of the same features as the English version of CFX Manager software version 1.5 and work with the regional language settings on both the Microsoft Windows® XP and Microsoft Windows Vista™ operating systems providing localized, language-specific environments.

For more information please visit

About Bio-Rad

Bio-Rad Laboratories, Inc. (, has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 85,000 research and industry customers worldwide through its global network of operations. The company employs over 6,500 people globally and had revenues exceeding $1.7 billion in 2008.

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, "believe," "expect," "may," "will," "intend," "estimate," "continue," or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company's risks and uncertainties, please refer to the "Risk Factors" in the Company's public reports filed with the Securities and Exchange Commission, including the Company's most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements.

Information in this release applies specifically to products available in the United States. Product availability and specifications may vary in non U.S. markets.

If you choose to review this item, your readers will receive the quickest response to their inquiries by emailing them to or by calling 1-800-424-6723.

For more information contact:
Ken Li, Chempetitive Group
P: 312-997-2436 x112 - kli[.]

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: Bio-Rad Laboratories, Inc.


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick NewswireToday Visibility Checker


Distribution / Indexing: [+]

# # #

  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

Bio-Rad Launches CFX Manager Software Version 1.5

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
Publisher Contact: Richard Kurtz - 
800-876-3425 x5638 Richard_Kurtz[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bio-Rad Laboratories, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From Bio-Rad Laboratories, Inc. / Company Profile

Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ipsen to Present 12 Abstracts At the 11th World Congress for Neurorehabilitation (WCNR) Virtual Congress
Imec Announces elPrep5 - the Newest Version of its Software Platform for DNA Analysis
Ipsen Showcases Commitment to Patient-centric Advances in Oncology with Record Number of Abstracts to be Presented At ESMO 2020 Virtual Congress
Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease Announced
Ipsen to Present New Insights At ASBMR for Potential Treatment of Ultra-rare Disease Fibrodysplasia Ossificans Progressiva (FOP)
Ipsen to Present Results from MOVE, the First Global Phase III Trial in Fibrodysplasia Ossificans Progressiva (FOP) At ASBMR 2020 Annual Meeting
DSM Ignites New Strategic Initiative to Transform Global Animal Nutrition and Health
Jamjoom Pharmaceuticals Earns Acclaim from Frost & Sullivan for its Dominance in the KSA Pharma Market
DSM and Avril Complete Creation of Joint Venture to Develop Plant-based Protein
Ipsen Joins Clinical Collaboration to Evaluate Cabozantinib (CABOMETYX®) Plus Atezolizumab in Metastatic Non-small Cell Lung Cancer
Stevanato Group, SCHOTT, and Gerresheimer Confirm the Readiness to Support Future Covid-19 Vaccine with Pharmaceutical Containers
Ipsen Receives FDA Fast Track Designation for Liposomal Irinotecan (ONIVYDE®) as A First-line Combination Treatment for Metastatic Pancreatic Cancer
Ipsen Demonstrates Continued Commitment to Rare Diseases with Eight Abstracts Accepted At ENDO 2020 Published in the Journal of the Endocrine Society
Waters Corporation Earns New Product Innovation Award with First SmartMS-enabled Biopharmaceutical Solution
DSM Boosts Maternal and Infant Nutrition Portfolio with New Plant-based High Potency DHA Oil

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business




  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (